canagliflozin/metformin (Invokamet)

From Aaushi

Jump to navigation Jump to search

^[1]

Indications

diabetes mellitus type 2

Adverse effects

see canagliflozin

drug adverse effects of hypoglycemic agents

More general terms

hypoglycemic combination

Components

References

↑ FDA Safety Alert. 09/10/2015 Invokana and Invokamet (canagliflozin): Drug Safety Communication
New Information on Bone Fracture Risk and Decreased Bone Mineral Density. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm461876.htm

Retrieved from "https://aaushi.info/w/index.php?title=A485606&oldid=944134"

↑ Back to top